DCF — ASCENSION CALUMET HOSPITAL
Enterprise Value: $11.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$11.0M
Enterprise Value
$2.4M
PV of Cash Flows
$8.6M
PV of Terminal Value
$13.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $33.4M | $1.9M | 6.0% | $0.2M | $0.2M |
| Year 2 | $34.4M | $2.3M | 7.0% | $0.5M | $0.4M |
| Year 3 | $35.4M | $2.7M | 8.0% | $0.8M | $0.6M |
| Year 4 | $36.5M | $3.0M | 8.0% | $0.9M | $0.6M |
| Year 5 | $37.6M | $3.2M | 8.0% | $1.0M | $0.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $11.0M. Terminal value accounts for 78% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$32.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.05153598143987421
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5